Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness

Ioana Mozos, Dana Stoian, Constantin Tudor Luca, Ioana Mozos, Dana Stoian, Constantin Tudor Luca

Abstract

Arterial stiffness is associated with cardiovascular risk, morbidity, and mortality. The present paper reviews the main vitamins related to arterial stiffness and enabling destiffening, their mechanisms of action, providing a brief description of the latest studies in the area, and their implications for primary cardiovascular prevention, clinical practice, and therapy. Despite inconsistent evidence for destiffening induced by vitamin supplementation in several randomized clinical trials, positive results were obtained in specific populations. The main mechanisms are related to antiatherogenic effects, improvement of endothelial function (vitamins A, C, D, and E) and metabolic profile (vitamins A, B12, C, D, and K), inhibition of the renin-angiotensin-aldosterone system (vitamin D), anti-inflammatory (vitamins A, D, E, and K) and antioxidant effects (vitamins A, C, and E), decrease of homocysteine level (vitamin B12), and reversing calcification of arteries (vitamin K). Vitamins A, B12, C, D, E, and K status is important in evaluating cardiovascular risk, and vitamin supplementation may be an effective, individualized, and inexpensive destiffening therapy.

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

    1. Cavalcante J. L., Lima J. A. C., Redheuil A., Al-Mallah M. H. Aortic stiffness: current understanding and future directions. Journal of the American College of Cardiology. 2011;57(14):1511–1522. doi: 10.1016/j.jacc.2010.12.017.
    1. Nordstrand N., Gjevestad E., Hertel J. K., et al. Arterial stiffness, lifestyle intervention and a low-calorie diet in morbidly obese patients—a nonrandomized clinical trial. Obesity. 2013;21(4):690–697. doi: 10.1002/oby.20099.
    1. Ben-Shlomo Y., Spears M., Boustred C., et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. Journal of the American College of Cardiology. 2014;63(7):636–646. doi: 10.1016/j.jacc.2013.09.063.
    1. Stricker H., Tosi Bianda F., Guidicelli-Nicolosi S., Limoni C., Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. European Journal of Vascular and Endovascular Surgery. 2012;44(3):307–312. doi: 10.1016/j.ejvs.2012.06.023.
    1. Patange A. R., Valentini R. P., Du W., Pettersen M. D. Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease. Pediatric Cardiology. 2012;33(1):122–128. doi: 10.1007/s00246-011-0101-y.
    1. Vlachopoulos C., Aznaouridis K., O'Rourke M. F., Safar M. E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. European Heart Journal. 2010;31(15):1865–1871. doi: 10.1093/eurheartj/ehq024.
    1. Dao H. H., Essalihi R., Bouvet C., Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovascular Research. 2005;66(2):307–317. doi: 10.1016/j.cardiores.2005.01.012.
    1. Doyon M., Mathieu P., Moreau P. Decreased expression of γ-carboxylase in diabetes-associated arterial stiffness: impact on matrix Gla protein. Cardiovascular Research. 2013;97(2):331–338.
    1. Karwowski W., Naumnik B., Szczepański M., Myśliwiec M. The mechanism of vascular calcification—a systematic review. Medical Science Monitor. 2012;18(1):RA1–RA11.
    1. O'Keefe J. H., Bergman N., Carrera-Bastos P., Fontes-Villalba M., DiNicolantonio J. J., Cordain L. Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart. 2016;3(1) doi: 10.1136/openhrt-2015-000325.e000325
    1. El Asmar M. S., Naoum J. J., Arbid E. J. Vitamin K dependent proteins and the role of vitamin K2 in the modulation of vascular calcification: a review. Oman Medical Journal. 2014;29(3):172–177. doi: 10.5001/omj.2014.44.
    1. Johnson R. C., Leopold J. A., Loscalzo J. Vascular calcification. Pathobiological mechanisms and clinical implications. Circulation Research. 2006;99(10):1044–1059. doi: 10.1161/01.res.0000249379.55535.21.
    1. Shanahan C. M., Crouthamel M. H., Kapustin A., Giachelli C. M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circulation Research. 2011;109(6):697–711. doi: 10.1161/circresaha.110.234914.
    1. Waśkiewicz A., Szcześniewska D., Szostak-Węgierek D., et al. Are dietary habits of the Polish population consistent with the recommendations for prevention of cardiovascular disease?—WOBASZ II Project. Kardiologia Polska. 2016;74(9):969–977. doi: 10.5603/kp.a2016.0003.
    1. Zureik M., Galan P., Bertrais S., et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24(8):1485–1491. doi: 10.1161/01.ATV.0000136648.62973.c8.
    1. Shargorodsky M., Debby O., Matas Z., Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutrition & Metabolism. 2010;7, article 55 doi: 10.1186/1743-7075-7-55.
    1. Estruch R., Ros E., Salas-Salvadó J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. The New England Journal of Medicine. 2013;368(14):1279–1290. doi: 10.1056/nejmoa1200303.
    1. McGreevy C., Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Annals of Internal Medicine. 2011;155(12):820–826. doi: 10.7326/0003-4819-155-12-201112200-00004.
    1. Mao X., Xing X., Xu R., et al. Folic acid and vitamins D and B12 correlate with homocysteine in chinese patients with type-2 diabetes mellitus, hypertension, or cardiovascular disease. Medicine. 2016;95(6) doi: 10.1097/md.0000000000002652.e2652
    1. Schwingshackl L., Hoffmann G., Buijsse B., et al. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials. Systematic Reviews. 2015;4, article no. 34 doi: 10.1186/s13643-015-0029-z.
    1. Forouhi N. G., Menon R. K., Sharp S. J., et al. Effects of vitamin D2 or D3 supplementation on glycemic control and cardiometabolic risk among people at risk of type 2 diabetes; results of a randomized double-blind placebo-controlled trial. Diabetes, Obesity and Metabolism. 2016;18(4):392–400. doi: 10.1111/dom.12625.
    1. Aytaç M. B., Deveci M., Bek K., Kayabey Ö., Ekinci Z. Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease. Pediatric Nephrology. 2016;31(2):267–277. doi: 10.1007/s00467-015-3220-5.
    1. Munisamy S., Daud K. M., Mokhtar S. S., Rasool A. H. G. Effects of 1α-calcidol (alfacalcidol) on microvascular endothelial function, arterial stiffness, and blood pressure in type II diabetic nephropathy patients. Microcirculation. 2016;23(1):53–61. doi: 10.1111/micc.12256.
    1. Zaleski A., Panza G., Swales H., et al. High-dose versus low-dose vitamin D supplementation and arterial stiffness among individuals with prehypertension and vitamin D deficiency. Disease Markers. 2015;2015:7. doi: 10.1155/2015/918968.918968
    1. McGreevy C., Barry M., Davenport C., et al. The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population. Journal of the American Society of Hypertension. 2015;9(3):176–183. doi: 10.1016/j.jash.2014.12.019.
    1. Gepner A. D., Haller I. V., Krueger D. C., Korcarz C. E., Binkley N., Stein J. H. A randomized controlled trial of the effects of vitamin D supplementation on arterial stiffness and aortic blood pressure in native American women. Atherosclerosis. 2015;240(2):526–528. doi: 10.1016/j.atherosclerosis.2015.04.795.
    1. Ryu O.-H., Chung W., Lee S., Hong K.-S., Choi M.-G., Yoo H. J. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean Journal of Internal Medicine. 2014;29(5):620–629. doi: 10.3904/kjim.2014.29.5.620.
    1. Chitalia N., Ismail T., Tooth L., et al. Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients. PLoS ONE. 2014;9(3) doi: 10.1371/journal.pone.0091363.e91363
    1. Martins D., Meng Y., Tareen N., et al. The effect of short term vitamin D supplementation on the inflammatory and oxidative mediators of arterial stiffness. Health. 2014;6(12):1503–1511. doi: 10.4236/health.2014.612185.
    1. Levin A., Perry T., De Zoysa P., et al. A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients. BMC Cardiovascular Disorders. 2014;14, article 156 doi: 10.1186/1471-2261-14-156.
    1. Mose F. H., Vase H., Larsen T., et al. Cardiovascular effects of cholecalciferol treatment in dialysis patients—a randomized controlled trial. BMC Nephrology. 2014;15(1, article 50) doi: 10.1186/1471-2369-15-50.
    1. Klop B., van de Geijn G.-J. M., Birnie E., et al. Vitamin D3 mediated effects on postprandial leukocyte activation and arterial stiffness in men and women. European Journal of Clinical Nutrition. 2014;68(5):635–637. doi: 10.1038/ejcn.2014.29.
    1. Dong Y., Stallmann-Jorgensen I. S., Pollock N. K., et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-Hydroxyvitamin D, adiposity, and arterial stiffness. The Journal of Clinical Endocrinology and Metabolism. 2010;95(10):4584–4591. doi: 10.1210/jc.2010-0606.
    1. Fulton R. L., McMurdo M. E. T., Hill A., et al. Effect of vitamin K on vascular health and physical function in older people with vascular disease—a randomised controlled trial. The Journal of Nutrition, Health & Aging. 2016;20(3):325–333.
    1. Knapen M. H. J., Braam L. A. J. L. M., Drummen N. E., Bekers O., Hoeks A. P. G., Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thrombosis and Haemostasis. 2015;113(5):1135–1144. doi: 10.1160/th14-08-0675.
    1. Vossen L. M., Schurgers L. J., van Varik B. J., et al. Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial) Nutrients. 2015;7(11):8905–8915. doi: 10.3390/nu7115443.
    1. Vucinovic Z., Duplancic D., Seselja-Perisin A., et al. Acute application of antioxidants protects against hyperoxia-induced reduction of plasma nitrite concentration. Clinical physiology and functional imaging. 2015;35(1):76–80. doi: 10.1111/cpf.12169.
    1. Hildreth K. L., Kohrt W. M., Moreau K. L. Oxidative stress contributes to large elastic arterial stiffening across the stages of the menopausal transition. Menopause. 2014;21(6):624–632. doi: 10.1097/GME.0000000000000116.
    1. Ives S. J., Harris R. A., Witman M. A., et al. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension. 2014;63(3):459–467. doi: 10.1161/hypertensionaha.113.02255.
    1. Veringa S. J. E., Nanayakkara P. W. B., Van Ittersum F. J., et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease. Clinical Nephrology. 2012;78(4):263–272. doi: 10.5414/cn107439.
    1. Rasool A. H. G., Rahman A. R. A., Yuen K. H., Wong A. R. Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E. Archives of Pharmacal Research. 2008;31(9):1212–1217. doi: 10.1007/s12272-001-1291-5.
    1. Kelly R., Poo Yeo K., Isaac H., et al. Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects. Free Radical Research. 2008;42(5):514–522. doi: 10.1080/10715760802087431.
    1. Plantinga Y., Ghiadoni L., Magagna A., et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. American Journal of Hypertension. 2007;20(4):392–397. doi: 10.1016/j.amjhyper.2006.09.021.
    1. Katayama Y., Shige H., Yamamoto A., Hirata F., Yasuda H. Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. Journal of atherosclerosis and thrombosis. 2004;11(6):354–357. doi: 10.5551/jat.11.354.
    1. Mullan B. A., Ennis C. N., Fee H. J. P., Young I. S., McCance D. R. Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia. American Journal of Physiology—Heart and Circulatory Physiology. 2004;287(3):H1262–H1268. doi: 10.1152/ajpheart.00153.2003.
    1. Mullan B. A., Young I. S., Fee H., McCance D. R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension. 2002;40(6):804–809. doi: 10.1161/01.HYP.0000039961.13718.00.
    1. Skyrme-Jones R. A. P., O'Brien R. C., Berry K. L., Meredith I. T. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. Journal of the American College of Cardiology. 2000;36(1):94–102. doi: 10.1016/s0735-1097(00)00720-8.
    1. Van Dijk S. C., Enneman A. W., Swart K. M. A., et al. Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial. Journal of Hypertension. 2015;33(9):1897–1906. doi: 10.1097/HJH.0000000000000647.
    1. Koyama K., Ito A., Yamamoto J., et al. Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis. American Journal of Kidney Diseases. 2010;55(6):1069–1078. doi: 10.1053/j.ajkd.2009.12.035.
    1. Llauradó G., Megia A., Cano A., et al. FGF-23/vitamin D axis in type 1 diabetes: the potential role of mineral metabolism in arterial stiffness. PLoS ONE. 2015;10(10) doi: 10.1371/journal.pone.0140222.e0140222
    1. Kaludjerovic J., Vieth R. Relationship between vitamin D during perinatal development and health. Journal of Midwifery & Women's Health. 2010;55(6):550–560. doi: 10.1016/j.jmwh.2010.02.016.
    1. Fouda M. A., Turkistani I. Z., Angkaya-Bagayawa F. F., et al. Vitamin D deficiency in young women of childbearing age: the elephant in the room. International Journal of Clinical and Experimental Medicine. 2016;9(2):4615–4619.
    1. Al Mheid I., Patel R. S., Tangpricha V., Quyyumi A. A. Vitamin D and cardiovascular disease: is the evidence solid? European Heart Journal. 2013;34(48):3691–3698. doi: 10.1093/eurheartj/eht166.
    1. Müller K., Bendtzen K. 1,25-dihydroxyvitamin d3 as a natural regulator of human immune functions. Journal of Investigative Dermatology Symposium Proceedings. 1996;1(1):68–71.
    1. Cantorna M. T., Snyder L., Lin Y.-D., Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7(4):3011–3021. doi: 10.3390/nu7043011.
    1. Tomson J., Emberson J., Hill M., et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. European Heart Journal. 2013;34(18):1365–1374. doi: 10.1093/eurheartj/ehs426.
    1. Lieberman R., Wadwa R. P., Nguyen N., et al. The association between vitamin D and vascular stiffness in adolescents with and without type 1 diabetes. PloS one. 2013;8(10):p. e77272. doi: 10.1371/journal.pone.0077272.
    1. Sypniewska G., Pollak J., Strozecki P., et al. 25-hydroxyvitamin D, biomarkers of endothelial dysfunction and subclinical organ damage in adults with hypertension. American Journal of Hypertension. 2014;27(1):114–121. doi: 10.1093/ajh/hpt174.
    1. Chang J., Ye X.-G., Hou Y.-P., Wu J.-L., Li S.-L., Sun Q.-M. Vitamin D level is associated with increased left ventricular mass and arterial stiffness in older patients with impaired renal function. Medical Science Monitor. 2015;21:3993–3999. doi: 10.12659/MSM.896559.
    1. Jha P., Dolan L. M., Khoury P. R., Urbina E. M., Kimball T. R., Shah A. S. Low serum vitamin D levels are associated with increased arterial stiffness in youth with type 2 diabetes. Diabetes Care. 2015;38(8):1551–1557. doi: 10.2337/dc15-0111.
    1. Sachs M. C., Brunzell J. D., Cleary P. A., et al. Circulating vitamin d metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care. 2013;36(8):2423–2429. doi: 10.2337/dc12-2020.
    1. van Dijk S. C., Sohl E., Oudshoorn C., et al. Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population. Age and ageing. 2015;44(1):136–142. doi: 10.1093/ageing/afu095.
    1. Rodríguez A. J., Scott D., Srikanth V., Ebeling P. Effect of vitamin D supplementation on measures of arterial stiffness: a systematic review and meta-analysis of randomized controlled trials. Clinical Endocrinology. 2016;84(5):645–657. doi: 10.1111/cen.13031.
    1. Charitaki E., Davenport A. Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues. Journal of Nephrology. 2014;27(4):431–437. doi: 10.1007/s40620-014-0040-9.
    1. Watson K. E., Boström K., Ravindranath R., Lam T., Norton B., Demer L. L. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. Journal of Clinical Investigation. 1994;93(5):2106–2113. doi: 10.1172/JCI117205.
    1. Mathew S., Lund R. J., Chaudhary L. R., Geurs T., Hruska K. A. Vitamin D receptor activators can protect against vascular calcification. Journal of the American Society of Nephrology. 2008;19(8):1509–1519. doi: 10.1681/ASN.2007080902.
    1. Chen S., Law C. S., Gardner D. G. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. The Journal of Steroid Biochemistry and Molecular Biology. 2010;118(3):135–141. doi: 10.1016/j.jsbmb.2009.11.002.
    1. Yun K.-J., Baek K.-H. Is vitamin D supplementation really effective in patients with type 2 diabetes? The Korean Journal of Internal Medicine. 2014;29(5):574–576. doi: 10.3904/kjim.2014.29.5.574.
    1. Hanks L. J., Casazza K., Judd S. E., Jenny N. S., Gutiérrez O. M., Sanchez-Margalet V. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults. PLOS ONE. 2015;10(3) doi: 10.1371/journal.pone.0122885.e0122885
    1. Saito Y., Yamagishi T., Nakamura T., et al. Klotho protein protects against endothelial dysfunction. Biochemical and Biophysical Research Communications. 1998;248(2):324–329. doi: 10.1006/bbrc.1998.8943.
    1. Timms P. M., Mannan N., Hitman G. A., et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? The Quarterly Journal of Medicine. 2002;95(12):787–796. doi: 10.1093/qjmed/95.12.787.
    1. Mozos I., Marginean O. Links between vitamin D deficiency and cardiovascular diseases. BioMed Research International. 2015;2015:12. doi: 10.1155/2015/109275.109275
    1. Shearer M. J., Newman P. Metabolism and cell biology of vitamin K. Thrombosis and Haemostasis. 2008;100(4):530–547. doi: 10.1160/TH08-03-0147.
    1. Geleijnse J. M., Vermeer C., Grobbee D. E., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. The Journal of Nutrition. 2004;134(11):3100–3105.
    1. Beulens J. W. J., Bots M. L., Atsma F., et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489–493. doi: 10.1016/j.atherosclerosis.2008.07.010.
    1. Mac-Way F., Poulin A., Utescu M. S. I., et al. The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study. Nephrology Dialysis Transplantation. 2014;29(11):2113–2120. doi: 10.1093/ndt/gfu224.
    1. Schurgers L. J., Uitto J., Reutelingsperger C. P. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends in Molecular Medicine. 2013;19(4):217–226. doi: 10.1016/j.molmed.2012.12.008.
    1. Liu Y.-P., Gu Y.-M., Thijs L., et al. Inactive matrix gla protein is causally related to adverse health outcomes: a mendelian randomization study in a flemish population. Hypertension. 2015;65(2):463–470. doi: 10.1161/hypertensionaha.114.04494.
    1. Proudfoot D., Shanahan C. M. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein (review article) Nephrology. 2006;11(5):455–461. doi: 10.1111/j.1440-1797.2006.00660.x.
    1. Pivin E., Ponte B., Pruijm M., et al. Inactive Matrix Gla-Protein is associated with arterial stiffness in an adult population-based study. Hypertension. 2015;66(1):85–92. doi: 10.1161/hypertensionaha.115.05177.
    1. Mayer O., Jr., Seidlerová J., Wohlfahrt P., et al. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. Journal of Human Hypertension. 2016;30(7):418–423. doi: 10.1038/jhh.2015.55.
    1. Gungor O., Kircelli F., Carrero J. J., et al. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients. Clinical Nephrology. 2011;75(6):491–496. doi: 10.5414/CNP75491.
    1. Danziger J., Young R. L., Shea M. K., et al. Vitamin K—dependent protein activity and incident ischemic cardiovascular disease: the multi-ethnic study of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36(5):1037–1042. doi: 10.1161/atvbaha.116.307273.
    1. Shea M. K., Booth S. L., Massaro J. M., et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study. American Journal of Epidemiology. 2008;167(3):313–320. doi: 10.1093/aje/kwm306.
    1. Ohsaki Y., Shirakawa H., Hiwatashi K., Furukawa Y., Mizutani T., Komai M. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Bioscience, Biotechnology and Biochemistry. 2006;70(4):926–932. doi: 10.1271/bbb.70.926.
    1. Krishnan S., Chawla N., Ezekowitz M. D., Peixoto A. J. Warfarin therapy and systolic hypertension in men with atrial fibrillation. American Journal of Hypertension. 2005;18(12):1592–1599. doi: 10.1016/j.amjhyper.2005.06.001.
    1. Vaccaro J. A., Huffman F. G. Phylloquinone (vitamin K1) intake and pulse pressure as a measure of arterial stiffness in older adults. Journal of Nutrition in Gerontology and Geriatrics. 2013;32(3):244–257. doi: 10.1080/21551197.2013.809045.
    1. Spronk H. M. H., Soute B. A. M., Schurgers L. J., Thijssen H. H. W., De Mey J. G. R., Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. Journal of Vascular Research. 2003;40(6):531–537. doi: 10.1159/000075344.
    1. Schmölz L., Birringer M., Lorkowski S. Complexity of vitamin E metabolism. World Journal of Biological Chemistry. 2016;7(1, article 14) doi: 10.4331/wjbc.v7.i1.14.
    1. Maes M., Weeckx S., Wauters A., et al. Biological variability in serum vitamin E concentrations: relation to serum lipids. Clinical Chemistry. 1996;42(11):1824–1831.
    1. Rimm E. B., Stampfer M. J., Ascherio A., Giovannucci E., Colditz G. A., Willett W. C. Vitamin E consumption and the risk of coronary heart disease in men. New England Journal of Medicine. 1993;328(20):1450–1456. doi: 10.1056/NEJM199305203282004.
    1. Stampfer M. J., Hennekens C. H., Manson J. E., Colditz G. A., Rosner B., Willett W. C. Vitamin E consumption and the risk of coronary disease in women. The New England Journal of Medicine. 1993;328(20):1444–1449. doi: 10.1056/nejm199305203282003.
    1. Shirpoor A., Norouzi L., Nemati S., Ansari M. H. K. Protective effect of vitamin E against diabetes-induced oxidized LDL and aorta cell wall proliferation in rat. Iranian Biomedical Journal. 2015;19(2):117–123. doi: 10.6091/ibj.1449.2015.
    1. Cominacini L., Garbin U., Pasini A. F., et al. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radical Biology and Medicine. 1997;22(1-2):117–127. doi: 10.1016/s0891-5849(96)00271-7.
    1. Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein kinase C. Circulation Research. 1994;74(4):565–575. doi: 10.1161/01.res.74.4.565.
    1. Bowry V. W., Mohr D., Cleary J., Stocker R. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. The Journal of Biological Chemistry. 1995;270(11):5756–5763. doi: 10.1074/jbc.270.11.5756.
    1. Miller E. R., III, Pastor-Barriuso R., Dalal D., Riemersma R. A., Appel L. J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine. 2005;142(1):37–46.
    1. Rietjens I. M. C. M., Boersma M. G., Haan L. D., et al. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environmental Toxicology and Pharmacology. 2002;11(3-4):321–333. doi: 10.1016/S1382-6689(02)00003-0.
    1. Ashor A. W., Siervo M., Lara J., Oggioni C., Afshar S., Mathers J. C. Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition. 2015;113(8):1182–1194. doi: 10.1017/s0007114515000227.
    1. Orbe J., Rodríguez J. A., Arias R., et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis. 2003;167(1):45–53. doi: 10.1016/s0021-9150(02)00392-1.
    1. Dusinska M., Kazimirova A., Barancokova M., et al. Nutritional supplementation with antioxidants decreases chromosomal damage in humans. Mutagenesis. 2003;18(4):371–376.
    1. Ashor A. W., Siervo M., Lara J., Oggioni C., Mathers J. C. Antioxidant vitamin supplementation reduces arterial stiffness in adults: a systematic review and meta-analysis of randomized controlled trials. Journal of Nutrition. 2014;144(10):1594–1602. doi: 10.3945/jn.114.195826.
    1. Hampson G., Edwards S., Sankaralingam A., et al. Circulating concentrations of vitamin E isomers: association with bone turnover and arterial stiffness in post-menopausal women. Bone. 2015;81:407–412. doi: 10.1016/j.bone.2015.08.010.
    1. Chin J. H., Azhar S., Hoffman B. B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. The Journal of Clinical Investigation. 1992;89(1):10–18. doi: 10.1172/jci115549.
    1. Wilkinson I. B., Cockcroft J. R., Webb D. J. Pulse wave analysis and arterial stiffness. Journal of Cardiovascular Pharmacology. 1998;32(supplement 3):S33–S37.
    1. Wigg S. J., Tare M., Forbes J., et al. Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-β in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia. 2004;47(6):1038–1046. doi: 10.1007/s00125-004-1411-x.
    1. Jurk D., Wilson C., Passos J. F., et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nature Communications. 2014;2, article 4172 doi: 10.1038/ncomms5172.
    1. Wannamethee S. G., Bruckdorfer K. R., Shaper A. G., Papacosta O., Lennon L., Whincup P. H. Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men. Circulation: Heart Failure. 2013;6(4):647–654. doi: 10.1161/CIRCHEARTFAILURE.112.000281.
    1. Devaraj S., Jialal I. Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? Nutrition Reviews. 2005;63(8):290–293. doi: 10.1301/nr.2005.aug.290-293.
    1. Okamura T., Moriyama Y., Kadowaki T., Kanda H., Ueshima H. Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with α-tocopherol in Japanese middle-aged male workers. Hypertension Research. 2004;27(3):173–180. doi: 10.1291/hypres.27.173.
    1. Park C. Y., Jung S., Kim M. K., et al. Habitual dietary intake of β-carotene, vitamin C, folate, or vitamin E may interact with single nucleotide polymorphisms on brachial–ankle pulse wave velocity in healthy adults. European Journal of Nutrition. 2016;55(2):855–866. doi: 10.1007/s00394-015-0896-z.
    1. Hagymási K., Egresi A., Lengyel G. Antioxidants—antioxidative stress? Facts and questions, 2015. Orvosi Hetilap. 2015;156(47):1884–1887. doi: 10.1556/650.2015.30302.
    1. Gómez-Marcos M. A., Blázquez-Medela A. M., Gamella-Pozuelo L., Recio-Rodriguez J. I., García-Ortiz L., Martínez-Salgado C. Serum superoxide dismutase is associated with vascular structure and function in hypertensive and diabetic patients. Oxidative Medicine and Cellular Longevity. 2016;2016:8. doi: 10.1155/2016/9124676.9124676
    1. Raitakari O. T., Adams M. R., McCredie R. J., Griffiths K. A., Stocker R., Celermajer D. S. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. Journal of the American College of Cardiology. 2000;35(6):1616–1621. doi: 10.1016/s0735-1097(00)00576-3.
    1. Wei W., Kim Y., Boudreau N. Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988–1994. American Journal of Public Health. 2001;91(2):258–264. doi: 10.2105/ajph.91.2.258.
    1. Wilkinson I. B., Megson I. L., MacCallum H., Sogo N., Cockcroft J. R., Webb D. J. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. Journal of Cardiovascular Pharmacology. 1999;34(5):690–693. doi: 10.1097/00005344-199911000-00010.
    1. Sabri M. R., Tavana E. N., Ahmadi A., Gheissari A. Effect of vitamin C on endothelial function of children with chronic renal failure: an experimental study. Advanced Biomedical Research. 2015;4(1, article 260) doi: 10.4103/2277-9175.172996.
    1. Murphy M. E. Ascorbate and dehydroascorbate modulate nitric oxide-induced vasodilations of rat coronary arteries. Journal of Cardiovascular Pharmacology. 1999;34(2):295–303. doi: 10.1097/00005344-199908000-00016.
    1. Wu J.-R., Kao L.-P., Wu B.-N., et al. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery. Kaohsiung Journal of Medical Sciences. 2015;31(5):241–254. doi: 10.1016/j.kjms.2015.02.005.
    1. Matthews K. A., Kuller L. H., Sutton-Tyrrell K., Chang Y.-F. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001;32(5):1104–1110. doi: 10.1161/01.STR.32.5.1104.
    1. Jackson T. S., Xu A., Vita J. A., Keaney J. F., Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circulation Research. 1998;83(9):916–922. doi: 10.1161/01.RES.83.9.916.
    1. Ellulu M. S., Rahmat A., Patimah I., Khaza’Ai H., Abed Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Design, Development and Therapy. 2015;9:3405–3412. doi: 10.2147/dddt.s83144.
    1. Giordano P., Scicchitano P., Locorotondo M., et al. Carotenoids and cardiovascular risk. Current Pharmaceutical Design. 2012;18(34):5577–5589. doi: 10.2174/138161212803307527.
    1. Karppi J., Kurl S., Ronkainen K., Kauhanen J., Laukkanen J. A. Serum carotenoids reduce progression of early atherosclerosis in the carotid artery wall among Eastern Finnish men. PLoS ONE. 2013;8(5) doi: 10.1371/journal.pone.0064107.e64107
    1. Kritchevsky S. B., Shimakawa T., Tell G. S., et al. Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation. 1995;92(8):2142–2150. doi: 10.1161/01.cir.92.8.2142.
    1. Rissanen T., Voutilainen S., Nyyssönen K., Salonen R., Salonen J. T. Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20(12):2677–2681. doi: 10.1161/01.ATV.20.12.2677.
    1. Wolak T., Paran E. Can carotenoids attenuate vascular aging? Vascular Pharmacology. 2013;59(3-4):63–66. doi: 10.1016/j.vph.2013.07.006.
    1. Mottaghi A., Ebrahimof S., Angoorani P., Saboor-Yaraghi A.-A. Vitamin A supplementation reduces IL-17 and RORc gene expression in atherosclerotic patients. Scandinavian Journal of Immunology. 2014;80(2):151–157. doi: 10.1111/sji.12190.
    1. Adaikalakoteswari A., Jayashri R., Sukumar N., et al. Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes. Cardiovascular Diabetology. 2014;13, article 129 doi: 10.1186/s12933-014-0129-4.
    1. Rafnsson S. B., Saravanan P., Bhopal R. S., Yajnik C. S. Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. European Journal of Nutrition. 2011;50(2):97–106. doi: 10.1007/s00394-010-0119-6.
    1. Su T.-C., Torng P.-L., Jeng J.-S., Chen M.-F., Liau C.-S. Arterial function of carotid and brachial arteries in postmenopausal vegetarians. Vascular Health and Risk Management. 2011;7(1):517–523. doi: 10.2147/VHRM.S18881.
    1. Shargorodsky M., Boaz M., Pasternak S., et al. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Diabetes/Metabolism Research and Reviews. 2009;25(1):70–75. doi: 10.1002/dmrr.902.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel